PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY
Clinical trials for PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY trials appear
Sign up with your email to follow new studies for PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New coaching program helps cancer patients tackle nerve pain their way
Symptom relief CompletedThis completed pilot study tested a behavioral program called PIVOT in 33 adults with chemotherapy-induced peripheral neuropathy. Participants worked with coaches to set personal health goals using a structured goal-setting method. The study aimed to see if this approach is safe …
Matched conditions: PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Study reveals hidden toll of chemo on hands: grip strength and quality of life under the microscope
Knowledge-focused CompletedThis completed study looked at how nerve damage from the chemotherapy drug oxaliplatin affects hand function, grip strength, and quality of life in 103 colorectal cancer patients. Researchers measured hand and finger strength, dexterity, and daily living abilities using standard …
Matched conditions: PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Patients help design device to stop chemo nerve damage
Knowledge-focused CompletedThis study involved 50 people with gastrointestinal cancer who had nerve pain from the chemotherapy drug oxaliplatin. Researchers interviewed patients to understand their symptoms and how the pain affected their daily life. The goal was to use this information to design a medical…
Matched conditions: PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY
Sponsor: Corporacion Parc Tauli • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC